Trials / Completed
CompletedNCT06661252
Evaluation of Nasal Biomarkers for Objective Assessment of Disease Severity in Respiratory Disorders
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 111 (actual)
- Sponsor
- Diag-Nose Medical Pty Ltd · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
This research study is an observational, single site study quantifying expression of biomarkers of respiratory disease in nasal fluid using the ABEL microsampler device. The primary objective of this study is to compare biomarker expression between healthy controls and participants with respiratory disorders such as chronic obstructive pulmonary disorder (COPD), hayfever, chronic sinusitis, asthma and rhinitis.
Conditions
- Chronic Obstructive Pulmonary Disease (COPD)
- Asthma Patients
- Asthma and Rhinitis
- Asthmatic Patients
- Asthma, Chronic Obstructive Pulmonary Disease (COPD)
- Rhinitis Allergic
- Rhinitis, Allergic, Perennial and/or Seasonal
- Non-allergic Rhinitis
- Chronic Sinusitis With or Without Nasal Polyps
- Healthy Volunteers
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | ABEL microsampler device | The ABEL microsampler device will be used to collect nasal fluid samples for biomarker analysis. |
Timeline
- Start date
- 2025-01-08
- Primary completion
- 2025-11-25
- Completion
- 2025-11-25
- First posted
- 2024-10-28
- Last updated
- 2026-04-13
Locations
1 site across 1 country: Australia
Source: ClinicalTrials.gov record NCT06661252. Inclusion in this directory is not an endorsement.